» Articles » PMID: 24455250

A Pharmacist-Led Point-of-Care INR Clinic: Optimizing Care in a Family Health Team Setting

Overview
Specialty Public Health
Date 2014 Jan 24
PMID 24455250
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose. Monitoring patients' international normalized ratio (INR) within a family medicine setting can be challenging. Novel methods of doing this effectively and in a timely manner are important for patient care. The purpose of this study was to determine the effectiveness of a pharmacist-led point-of-care (POC) INR clinic. Methods. At a community-based academic Family Health Team in Toronto, Canada, charts of patients with atrial fibrillation managed by a pharmacist with usual care (bloodtesting at lab and pharmacist follow up of INR by phone) from February 2008 to April 2008 were compared with charts of patients attending a weekly POC INR clinic from February 2010 to April 2010. Time in therapeutic range (TTR) was measured for both groups. Results. 119 patient charts were reviewed and 114 had TTR calculated. After excluding patients with planned inconsistent Coumadin use (20), such as initiating Coumadin treatment or stopping for a surgical procedure, the mean TTR increased from 64.41% to 77.09% with the implementation of the POC clinic. This was a statistically significant difference of 12.68% (CI: 1.18, 24.18; P = 0.03). Conclusion. A pharmacist-led POC-INR clinic improves control of anticoagulation therapy in patients receiving warfarin and should be considered for implementation in other family medicine settings.

Citing Articles

Pharmacy-Led Management of Atrial Fibrillation: Improving Treatment Adherence and Patient Outcomes.

Veale E Integr Pharm Res Pract. 2024; 13:101-114.

PMID: 39101005 PMC: 11297543. DOI: 10.2147/IPRP.S397844.


Stroke Risk Reduction in Atrial Fibrillation Through Pharmacist Prescribing: A Randomized Clinical Trial.

Sandhu R, Fradette M, Lin M, Youngson E, Lau D, Bungard T JAMA Netw Open. 2024; 7(7):e2421993.

PMID: 39046741 PMC: 11270136. DOI: 10.1001/jamanetworkopen.2024.21993.


Outpatient treatment of pulmonary embolism.

Bellou E, Keramida E, Karampinis I, Dimakakos E, Misthos P, Demertzis P Breathe (Sheff). 2021; 16(3):200069.

PMID: 33447272 PMC: 7792861. DOI: 10.1183/20734735.0069-2020.


The Evolving Role and Impact of Integrating Pharmacists into Primary Care Teams: Experience from Ontario, Canada.

Khaira M, Mathers A, Benny Gerard N, Dolovich L Pharmacy (Basel). 2020; 8(4).

PMID: 33297509 PMC: 7768418. DOI: 10.3390/pharmacy8040234.


Drive-Through Model for Anticoagulation Clinics During the COVID-19 Pandemic.

Bookani K, Minga I, Chander M, Hankewych K, Plassmeier M, Tafur A Clin Appl Thromb Hemost. 2020; 26:1076029620947476.

PMID: 32822220 PMC: 7444151. DOI: 10.1177/1076029620947476.


References
1.
Ogilvie I, Newton N, Welner S, Cowell W, Lip G . Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med. 2010; 123(7):638-645.e4. DOI: 10.1016/j.amjmed.2009.11.025. View

2.
Levine M, Shao W, Klein D . Monitoring of international normalized ratios: comparison of community nurses with family physicians. Can Fam Physician. 2012; 58(8):e465-71. PMC: 3419004. View

3.
Garwood C, Dumo P, Baringhaus S, Laban K . Quality of anticoagulation care in patients discharged from a pharmacist-managed anticoagulation clinic after stabilization of warfarin therapy. Pharmacotherapy. 2007; 28(1):20-6. DOI: 10.1592/phco.28.1.20. View

4.
Rosendaal F, Cannegieter S, van der Meer F, Briet E . A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost. 1993; 69(3):236-9. View

5.
Gill J, Landis M . Benefits of a mobile, point-of-care anticoagulation therapy management program. Jt Comm J Qual Improv. 2002; 28(11):625-30. DOI: 10.1016/s1070-3241(02)28066-9. View